1、Table of ContentsAs filed with the Securities and Exchange Commission on June 7,2023.Registration No.333-UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,DC 20549FORM S-1REGISTRATION STATEMENTUnderTHE SECURITIES ACT OF 1933Heart Test Laboratories,Inc.(Exact name of registrant as specified i
2、n its charter)Texas 334510 26-1344466(State or other jurisdiction ofincorporation or organization)(Primary Standard IndustrialClassification Code Number)(I.R.S.EmployerIdentification Number)550 Reserve St,Suite 360Southlake,Texas 76092682-237-7781(Address,including zip code,and telephone number,incl
3、uding area code,of registrants principal executive offices)Danielle Watson550 Reserve St,Suite 360Southlake,Texas 76092682-237-7781(Name,address,including zip code,and telephone number,including area code,of agent for service)Copies to:Sasha AblovatskiyJonathan ShechterFoley Shechter Ablovatskiy LLP
4、1180 Avenue of the Americas,8th FloorNew York,New York 10036Tel:(212)335-0466 David E.DanovitchAngela GomesSullivan&Worcester LLP1633 BroadwayNew York,New York 10019(212)660-3000Approximate date of commencement of proposed sale to the public:As soon as practicable after the effective date of this Re
5、gistration Statement.If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933,check thefollowing box:If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)u
6、nder the Securities Act,please check the following box and list the SecuritiesAct registration statement number of the earlier effective registration statement for the same offering.If this Form is a post-effective amendment filed pursuant to Rule 462(c)under the Securities Act,check the following b